FOI release

PAR for Mirtazapine 15 mg/ml oral solutions-PL 00427/0241

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00212

Received 26 February 2026

Published 14 April 2026

Request

We would like to request a copy of the Public Assessment report (UK PAR) and information if its Initial application or MA transferred application of the following product under the Freedom of Information Act (FOIA) of MHRA: Product name: Mirtazapine 15 mg/ml oral solution MAH name: Rosemont Pharmaceuticals Ltd Rosemont House Yorkdale Industrial Park Braithwaite Street Leeds LS11 9XE UK PL number: PL 00427/0241

Response

See attached

Documents

• FOI2026_00212 (redacted).pdf (488.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.